Our Publications
Our Research
Key Trials
Patient Education
Clinical Tools
Webcasts
- E-module 1: Ocular Blood Flow Anatomy
- Glaucoma Crossfire Season 1
- Ocular Blood Flow in Glaucoma Management
- Glaucoma - From Diagnosis to Management
- E- Module 6: Indian Perspective on Ocular Blood Flow
- E- Module 5: Role of Anti-Glaucoma Medication and Ocular Blood Flow
- E- Module 4: Clinical Significance of Ocular Blood flow in Glaucoma
- E- Module 3: Methods to Measure Ocular Blood Flow
- Non-IOP Risk Factors in The Management of Glaucoma
- E-module 2: Perfusion Pressure & Auto Regulation in Glaucoma
- Future Goals of Glaucoma Treatment: Ocular Blood Flow – What’s New?
- Trabeculectomy and Other Newer Glaucoma Surgeries
- Angle-Closure Glaucoma
- All about Gonioscopy
- A Relook at Glaucoma Therapy Beyond IOP Control
Our Publications
- Hypertension and Eye-Issue 2
- Effects of Exercise on Ocular Health
- Dorzox Datasheet
- Neuroprotection Update 4 - Neuroprotection of Photoreceptor Cells in Rod-Cone Dystrophies
- Neuroprotection Update 3- Neuroprotective Effects of Brimonidine
- Neuroprotection Update 2- Glaucoma
- Neuroprotection Update 1- Neuroprotective Strategies for Glaucoma
- Comparison Between Latanoprost, Travoprost and Bimatoprost
- Primary Open Angle Glaucoma: An Overview on Medical Therapy
Key Trials
- Meta-Analysis of Prostaglandin Analogues for Treating IOP in Patients with POAG or OHT
- Improved Discrimination between NTG and POAG: Insights from the Leuven Eye Study
- Impact of Topical Carbonic Anhydrase Inhibitors on Ocular Blood Flow: Literature Review and Meta-analysis
- Dorzolamide/Timolol vs. Brinzolamide/Timolol Fixed Combinations in Patients with POAG/NTG
- Migraine and Elevated IOP Increase the Risk of Low Ocular Perfusion Pressure, May Associate with Increased Risk of Glaucoma
- First-Line Treatment of Primary Open-Angle Glaucoma: Which is the Most Effective Agent?
- Impact of Long-Term Prostaglandin Analogue Treatment on IOP in POAG Patients
Patient Education
Clinical Tools
- Commonly seen Glaucomas and Related Conditions – Issue VII
- Commonly seen Glaucomas and Related Conditions – Issue VI
- Commonly seen Glaucomas and Related Conditions – Issue V
- Commonly seen Glaucomas and Related Conditions – Issue IV
- Commonly Seen Glaucomas and Related Conditions-Issue III
- Commonly seen Glaucomas and Related Conditions – Issue II
- Commonly seen Glaucomas and Related Conditions – Issue I
- Recent Modalities in the Diagnosis and Management of Glaucoma
- Classification of Medications and Adverse Events
- Primary Open Angle Glaucoma
- OPD Procedures
Webcasts
- A Spotlight on Ocular Surface & OT Protocols
- Microbial Keratitis – All You Wanted to Know but Didn’t Want to Ask!
- Dealing with the Painful Eye
- Herpetic Keratitis
- Management of Complications in Uveitis
- Management of Infectious Uveitis
- Basics of Uveitis (A) Sun Classifications/Terminologies and (B) Approach to Uveitis
- Investigations in Uveitis - Lab & Ancillary – When and How
- All about Viral Keratitis
- Perspectives on Infection Control in Ocular Surgery
- Infectious Keratitis and Its Management
- Red Eye: Differential Diagnosis
- Intracameral use of Antibiotics
Our Publications
- Surgical Insight: Part 2 - Keratoconus and its Management
- Surgical Insight - A Review on Surface Ablation Techniques
- Surgical Insight: Part 1 - Keratoconus and its Management
- Acute Red Eye: Diagnosis and Treatment
- Acute Red Eye: Differential Diagnosis
- Common Eyelid Disorders Seen in Everyday Practice
- The Management of Allergic Eye Diseases in Primary Eye Care
Our Research
Key Trials
- Cataract Surgery Antibiotic Prophylaxis: The Practice Pattern in India
- Pathogen Distribution and Antibiotic Sensitivity in Ocular Bacterial Infections
- Intracameral Moxifloxacin Safe in Children for Reducing the Risk of Endophthalmitis after Cataract Surgery
- Topical Moxifloxacin 0.5% vs. Gatifloxacin 0.5% as a Prophylactic Measure before Intraocular Surgery
- SCUT: Impact of Adjunctive Topical Corticosteroids on Treatment Outcomes in Bacterial Keratitis
- Comparison of Natamycin vs. Voriconazole for Treating Fungal Keratitis: MUTT-I Trial
